The U.S. Food and Drug Administration is issuing warning letters to firms for selling fraudulent products with claims to prevent, treat, mitigate, diagnose or cure coronavirus disease 2019 (COVID-19).
The FDA is actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims and is exercising its authority to protect consumers from firms selling unapproved products and making false or misleading claims, including, by pursuing warning letters, seizures, injunctions, or criminal prosecutions against products and firms or individuals that violate the law.
The FDA is actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims
